Sign in

CIK 0000875045 · Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330112644
Phone
6176792000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 5 Insider Annual Insider Trading Report
  5. 5 Insider Annual Insider Trading Report
  6. 4 Grant or award Chief Accounting Officer acquired 887 shares (grant or award)
  7. 4 Grant or award Head of Development acquired 1,123 shares (grant or award)
  8. 4 Grant or award Head of Pharm Ops and Tech acquired 1,340 shares (grant or award)
  9. 4 Grant or award Head of Alzheimer's Disease acquired 1,783 shares (grant or award)
  10. 4 Grant or award EVP, Human Resources acquired 4,452 shares (grant or award)
  11. 4 Grant or award EVP Chief Legal Off & Corp Sec acquired 5,703 shares (grant or award)
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 4 Open-market sale EVP, Human Resources sold 5,610 shares at $300.11 ($1,683,617)
  15. 4 Shares withheld for taxes Chief Accounting Officer gave up 156 shares (to pay taxes)
  16. 4 Shares withheld for taxes Head of Alzheimer's Disease gave up 759 shares (to pay taxes)
  17. 4 Shares withheld for taxes Head of Pharm Ops and Tech gave up 39 shares (to pay taxes)
  18. 4 Derivatives Options or other derivatives
  19. 3 Insider Initial Statement of Ownership
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 17 of 137 · 2,721 filings